Discovery of Dual Inhibitors of MDM2 and XIAP for Cancer Treatment

被引:72
作者
Gu, Lubing [1 ]
Zhang, Hailong [1 ]
Liu, Tao [1 ]
Zhou, Sheng [3 ]
Du, Yuhong [2 ]
Xiong, Jing [3 ]
Yi, Sha [1 ]
Qu, Cheng-Kui [1 ]
Fu, Haian [2 ]
Zhou, Muxiang [1 ]
机构
[1] Emory Univ, Sch Med, Aflac Canc & Blood Disorders Ctr, Div Hematol Oncol,Dept Pediat, 1760 Haygood Dr, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Pharmacol, Emory Chem Biol Discovery Ctr, Atlanta, GA 30322 USA
[3] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Pathol, Wuhan 430030, Peoples R China
基金
中国国家自然科学基金;
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; MESSENGER-RNA STABILIZATION; SMALL-MOLECULE INHIBITORS; WILD-TYPE P53; PROTEIN OVEREXPRESSION; APOPTOSIS PROTEINS; GENE AMPLIFICATION; CELLS; ACTIVATION; PATHWAY;
D O I
10.1016/j.ccell.2016.08.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MDM2 and XIAP are mutually regulated. Binding of MDM2 RING protein to the IRES region on XIAP mRNA results in MDM2 protein stabilization and enhanced XIAP translation. In this study, we developed a protein-RNA fluorescence polarization (FP) assay for high-throughput screening (HTS) of chemical libraries. Our FP-HTS identified eight inhibitors that blocked the MDM2 protein XIAP RNA interaction, leading to MDM2 degradation. The compound-induced MDM2 downregulation resulted not only in inhibition of XIAP expression, but also in activation of p53, which contributed to cancer cell apoptosis in vitro and inhibition of cancer cell proliferation in vivo. Importantly, one of the MDM2/XIAP inhibitors, MX69, showed minimal inhibitory effect on normal human hematopoiesis in vitro and was very well tolerated in animal models.
引用
收藏
页码:623 / 636
页数:14
相关论文
共 42 条
[1]   Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells [J].
Berezovskaya, O ;
Schimmer, AD ;
Glinskii, AB ;
Pinilla, C ;
Hoffman, RM ;
Reed, JC ;
Glinsky, GV .
CANCER RESEARCH, 2005, 65 (06) :2378-2386
[2]  
BUESORAMOS CE, 1993, BLOOD, V82, P2617
[3]   p53 mrNA controls p53 activity by managing Mdm2 functions [J].
Candeias, Marco M. ;
Malbert-Colas, Laurence ;
Powell, Darren J. ;
Daskalogianni, Chrysoula ;
Maslon, Magda M. ;
Naski, Nadia ;
Bourougaa, Karima ;
Calvo, Fabien ;
Fahraeus, Robin .
NATURE CELL BIOLOGY, 2008, 10 (09) :1098-1105
[4]   Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML [J].
Carter, Bing Z. ;
Mak, Duncan H. ;
Schober, Wendy D. ;
Koller, Erich ;
Pinilla, Clemencia ;
Vassilev, Lyubomir T. ;
Reed, John C. ;
Andreeff, Michael .
BLOOD, 2010, 115 (02) :306-314
[5]   High-throughput screening fluorescence polarization assay for tumor-specific Hsp90 [J].
Du, Yuhong ;
Moulick, Kamalika ;
Rodina, Anna ;
Aguirre, Julia ;
Felts, Sara ;
Dingledine, Raymond ;
Fu, Haian ;
Chiosis, Gabriela .
JOURNAL OF BIOMOLECULAR SCREENING, 2007, 12 (07) :915-924
[6]   MOLECULAR AND BIOCHEMICAL PHARMACOLOGY OF MITOXANTRONE [J].
DURR, FE ;
WALLACE, RE ;
CITARELLA, RV .
CANCER TREATMENT REVIEWS, 1983, 10 :3-&
[7]   MDM2 regulates MYCN mRNA stabilization and translation in human neuroblastoma cells [J].
Gu, L. ;
Zhang, H. ;
He, J. ;
Li, J. ;
Huang, M. ;
Zhou, M. .
ONCOGENE, 2012, 31 (11) :1342-1353
[8]   Regulation of XIAP Translation and Induction by MDM2 following Irradiation [J].
Gu, Lubing ;
Zhu, Ningxi ;
Zhang, Hongying ;
Durden, Donald L. ;
Feng, Yue ;
Zhou, Muxiang .
CANCER CELL, 2009, 15 (05) :363-375
[9]   Mdm2 promotes the rapid degradation of p53 [J].
Haupt, Y ;
Maya, R ;
Kazaz, A ;
Oren, M .
NATURE, 1997, 387 (6630) :296-299
[10]   Crosstalk between MYCN and MDM2-p53 signal pathways regulates tumor cell growth and apoptosis in neuroblastoma [J].
He, Jing ;
Gu, Lubing ;
Zhang, Hailong ;
Zhou, Muxiang .
CELL CYCLE, 2011, 10 (17) :2994-3002